Clinical Trial

Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 15, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-16
notable Primary completion pushed: 2026-03-20 -> 2026-07-31 2026-07-16
Trial Details
NCT Number NCT07316088
Lead Sponsor Oui Therapeutics, Inc.
Collaborators: National Institute of Mental Health (NIMH), Florida State University
Conditions PTSD, Post Traumatic Stress Disorder
Enrollment 40 participants
Start Date 2025-12-09
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-08-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-15